T45.1X
Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T45.1X refers to cases involving poisoning, adverse effects, or underdosing of antineoplastic and immunosuppressive drugs. These medications are crucial in the treatment of cancer and autoimmune diseases but can cause significant health issues if not used correctly. Recognizing the potential risks and understanding the implications of this code can help in better management and awareness of such drug-related problems.
Causes & Symptoms
Clinical Causes: Accidental overdose or underdose of antineoplastic or immunosuppressive medications Medication errors during prescribing, dispensing, or administration Intentional overdose or misuse of these drugs Lack of adherence to prescribed treatment plans Drug interactions that enhance toxicity or reduce effectiveness Metabolic or genetic factors affecting drug processing
Key Symptoms: Nausea and vomiting Malaise or general weakness Fever and chills Signs of infection due to immune suppression Unusual bleeding or easy bruising Signs of organ toxicity, such as jaundice or kidney dysfunction Severe bone marrow suppression leading to anemia or low blood cell counts Digestive issues including diarrhea or constipation
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough review of the patient's medical history, medication use, and the timing of symptom onset. Laboratory tests are crucial and may include:
Treatment Protocols: Management of poisoning or adverse effects related to these drugs typically includes:
Clinical Advice & FAQs
Billing Guidance
Is T45.1X a billable ICD-10 code?
Yes, T45.1X is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.1X?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference